C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 99 filers reported holding C4 THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $301,065 | -51.4% | 161,863 | -28.1% | 0.00% | – |
| Q2 2023 | $619,278 | -26.4% | 225,192 | -16.0% | 0.00% | – |
| Q1 2023 | $841,730 | +312.8% | 268,067 | +675.6% | 0.00% | – |
| Q4 2022 | $203,910 | -58.0% | 34,561 | -37.6% | 0.00% | – |
| Q3 2022 | $486,000 | +133.7% | 55,370 | +100.6% | 0.00% | – |
| Q2 2022 | $208,000 | -91.9% | 27,600 | -74.0% | 0.00% | – |
| Q1 2022 | $2,572,000 | -23.2% | 106,020 | +1.9% | 0.00% | – |
| Q4 2021 | $3,350,000 | -46.4% | 104,058 | -25.6% | 0.00% | -100.0% |
| Q3 2021 | $6,252,000 | +215.1% | 139,915 | +166.9% | 0.00% | – |
| Q2 2021 | $1,984,000 | +755.2% | 52,427 | +735.9% | 0.00% | – |
| Q1 2021 | $232,000 | – | 6,272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $39,840,000 | 3.87% |
| Paradigm Biocapital Advisors LP | 499,496 | $12,118,000 | 3.20% |
| Cypress Point Wealth Management, LLC | 118,573 | $2,877,000 | 2.92% |
| COMMODORE CAPITAL LP | 481,094 | $11,671,000 | 2.61% |
| Nextech Invest Ltd. | 375,857 | $9,118,000 | 2.60% |
| RTW INVESTMENTS, LP | 4,531,982 | $109,946,000 | 2.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 362,528 | $8,795,000 | 1.24% |
| Perceptive Advisors | 2,082,723 | $50,526,000 | 1.01% |
| CLOUGH CAPITAL PARTNERS L P | 356,181 | $8,641,000 | 0.66% |
| HighVista Strategies LLC | 34,760 | $843,000 | 0.54% |